Concurrently, these sEVs serve as carriers of miR-19b-3p to target recipient cells and orchestrate EMT in ccRCC by targeting PTEN, thus heightening RCC cells’ metastatic capacity. This evidence concerns the gene PTEN and renal cell carcinoma.